510(k) device
DeepXray Spina
Alpha Intelligence Manifolds, Inc. · Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density (SAO, Class II) · First FDA decision Jun 10, 2026, newest Jun 10, 2026Osteoporosis and fragility fractures
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "DeepXray Spina"
MAUDE reports
0
Brand "DeepXray Spina", since 2015
PubMed studies
2
Mentioning "DeepXray Spina"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DeepXray Spina
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- DeepXray Spina510(k)
K253192 · Decided Jun 10, 2026 · 257 days after receipt
Device type: Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density (SAO) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bone (Mineral) Density StudiesNational determinationOn the books150.3Updated Nov 4, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "DeepXray Spina", any status and sponsor, newest update first.
No registered device study names "DeepXray Spina".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DeepXray Spina", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SAO
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DeepXray Spina"[tiab]. The summary above synthesizes these.
- Osteoporosis prediction from Frontal Lumbar Spine X-rays.
Inamori R, Kobayashi T, Takaya E, et al. · J Clin Densitom · 2026
- AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study.
Tseng TH, Huang TT, Huang JE, et al. · Osteoporos Int · 2026Comparative Study
Other devices of this type
Also filed under product code SAO.
- OsteoSight Spine (v1)Naitive Technologies, Ltd. · 510(k) 2026
- Rho16 Bit, Inc. · De Novo 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.